Striverdi Respimat

Striverdi Respimat is an inhaled bronchodilator used for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). This prescription medication helps open airways to improve breathing. It is not a rescue inhaler. Always follow your healthcare provider's guidance.

Striverdi Respimat, containing olodaterol, is primarily used for the long-term management of airflow obstruction in adults with chronic obstructive pulmonary disease (COPD). It belongs to a class of medications called long-acting beta-agonists (LABAs), which help relax and open airways to make breathing easier. This medication is not intended for sudden breathing problems or as a rescue treatment. It is designed for regular daily use to control symptoms.

Striverdi Respimat works by relaxing the muscles in the airways, allowing them to stay open longer. This can help reduce symptoms such as wheezing, shortness of breath, and chest tightness. Users may notice improved ability to engage in daily activities with less breathing difficulty. Effects typically develop over time with consistent use.

Store Striverdi Respimat at room temperature, away from moisture and heat. Keep the inhaler in its original packaging until ready to use. Do not expose the device to extreme temperatures or puncture it. Always check the dose counter before use to ensure you have remaining doses. Discard the inhaler after the labeled number of doses has been used.

Striverdi Respimat may interact with other medications, particularly beta-blockers, which can reduce its effectiveness. Use caution with other inhaled medications that contain long-acting beta-agonists to avoid overuse. Avoid combining with stimulants or caffeine in large amounts, as this may increase side effects like jitteriness. Always inform your healthcare provider about all medications and supplements you are taking.